Close Menu
    What's Hot

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Litigation

    Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

    July 22, 2026

    South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

    July 22, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026

      UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

      July 20, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreased During June

      July 20, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    New Insights from Wearable Technology Data Could Have Significant Impact on Longevity and Mortality Markets

    Mortality March 13, 2025By Greg Winterton
    Share
    Twitter LinkedIn Email

    Scientists generally agree that walking for regular activity can help reduce the risk of health problems such as heart disease, obesity, diabetes, high blood pressure and even depression. Whilst the often touted ’10,000 steps per day’ figure is not a scientifically proven threshold, it has become a general guideline, one that many people are now able track, thanks to their smartphone. 

    And now, a new paper, Physical activity data from wearables from Klarity and Munich Life Re US has examined physical activity data from wearable technology and tied this data to mortality risk. 

    The study leveraged UK Biobank data that included over 58,631 lives (and 837 deaths). 

    Among the findings include: Individuals walking at least 7,000 steps per day experience significantly lower mortality risk, regardless of BMI, age, or smoking status; smokers with a daily step count of at least 7,000 have better mortality than non-smokers with fewer than 5,000 daily steps; obese participants with at least 7,000 daily steps have 40% lower mortality than “normal” BMI participants with a daily step count below 5,000; and pre-diabetics with at least 7,000 daily steps have a 60% lower mortality risk than individuals with normal A1C who walk fewer than 5,000 daily steps. 

    The findings could be significant for underwriters in the life insurance market. 

    “This research demonstrates the potential of using data from wearables to segment risk and potentially expand insurability,” said Dr. Gina Guzman, Chief Medical Officer at Munich Re Life US.  

    “Wearable data can be a window into the real-time health and lifestyle habits of applicants and may allow insurers to create more accurate and inclusive underwriting while simultaneously encouraging healthier behaviors among policyholders.” 

    Underwriters would first need to incorporate the data from wearable technology into their process, something which is already technically feasible, and an endeavour that is not as difficult as it might appear on the surface. 

    “Integrating wearable data into life insurance processes has never been easier. Policyholders can sync their wearable devices with a single implementation, and over the past seven to eight years, standardisation efforts have significantly improved. Insurers can start leveraging step count data from smartphones immediately as a first step, with broader wearable integration achievable in the near term,” said Will Cooper, Founder and CEO of Klarity. 

    Indeed, some insurers already have an existing program, like John Hancock’s Vitality, a rewards program that “rewards members for their everyday healthy activities, like walking the dog, going to the doctor and buying healthy food.”  

    And Vitality Insurance in the UK – owned by Discovery Holdings – also has a rewards program where customers can connect to their app and link up with a fitness tracker, so there is already activity in this space.  

    So, it would appear that the proof of concept and the technical wherewithal is already in place. Which just leaves the challenge of getting someone to actually engage with this new digital frontier. 

    In the life settlement market, one might be forgiven for thinking that this might be a tough ask. The cohort of insureds that participate in the space are healthier and wealthier than the average individual, and crucially, older, which many assume means that they are less likely to engage with the latest and greatest in technology developments. Not necessarily, according to Cooper. 

    “Even retirees – who may be less likely to use wearable technology – normally have smartphones, which already track step count passively,” he said. 

    “This provides an easy entry point for life insurers looking to enhance risk stratification for this demographic. Encouraging policyholders to sync their devices or participate in step-tracking initiatives can help insurers gather valuable mortality-related insights without requiring widespread adoption of additional wearables.” 

    It is not only life insurers who would be able to use this data and technology to better understand the mortality profile of the older cohort. Specialist life expectancy underwriters, who provide life expectancy reports to asset managers both during the original policy acquisition stage and afterwards (to keep the portfolio valuation up to date) could benefit here. 

    “These specialists can certainly leverage this data and insight provided that data privacy regulations are met and individual’s opt-in to share their wearable data. Our role is to help insurers and underwriters stratify risk more effectively while maintaining compliance with privacy laws,” said Cooper. 

    The pension risk transfer market is another area which could be impacted by the incorporation of wearable technology data into the underwriting process. 

    “Better mortality data can have a direct impact on pension risk transfer deals, which involve thousands of individuals,” said Cooper.  

    “More accurate risk stratification means insurers can price these deals with greater precision, reducing uncertainty.” 

    There are accuracy and manipulation risks, and not everyone carries their phone all the time, which could lead to gaps in data. Also, there are fairness and ethical Issues – would it be fair to penalise someone who doesn’t walk a lot due to a disability or job constraints? Would insurers reward active people with lower premiums and charge sedentary ones more? 

    Those are the questions that will need to be answered if this kind of data were to ever be adopted by the life insurance industry en masse. But, as with many new developments, it’s a case of one thing at a time. 

    “Carriers looking to incorporate third-party or wearables data will first want to conduct a pilot to assess participation rates and estimate baseline activity patterns,” said Guzman.  

    “We aim to provide tailored support and guidance to carriers considering using these new data sources in their underwriting programs.” 

    2025 - March Clinical Mortality Volume 4 Issue 3 - March 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026By Mark McCord

    The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

    June 10, 2026By Mark McCord

    Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

    April 9, 2026By Mark McCord

    Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

    March 25, 2026By Mark McCord
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.